Mitchell Lawrence Jones - 04 Sep 2025 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
Chief Medical Officer
Signature
/s/ Ryker Willie, Attorney-in-Fact
Issuer symbol
PALI
Transactions as of
04 Sep 2025
Net transactions value
$0
Form type
4
Filing time
05 Sep 2025, 09:00:35 UTC
Previous filing
13 Feb 2025
Next filing
08 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jones Mitchell Lawrence Chief Medical Officer 1902 WRIGHT PLACE, SUITE 200, CARLSBAD, /s/ Ryker Willie, Attorney-in-Fact 05 Sep 2025 0001993292

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Phantom Units Award $0 +289,000 $0.000000 289,000 04 Sep 2025 Common Stock 289,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.
F2 The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.
F3 Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan.

Remarks:

Exhibit 24 - Power of Attorney